The effects of biological disease-modifying antirheumatic drugs (bDMARDs) in the clinical
course of COVID-19 on children with underlying rheumatologic diseases have not been fully …

… Ayşenur PAÇ KISAARSLAN, corresponding author 1 Betül SÖZERİ, 2 Nihal ŞAHİN, 1
Sümeyra ÖZDEMİR ÇİÇEK, 1 Zübeyde GÜNDÜZ, 1 Erkan DEMİRKAYA, 3 Afig BERDELİ, 4 …

Introduction Neuropsychiatric (NP) involvement is a restricted area in juvenile-onset systemic
lupus erythematosus (jSLE). Aim To investigate the prevalence, demographic and clinical …

Objective Antineutrophil cytoplasmic antibody (ANCA)–associated vasculitides (AAV) are
very rare in childhood with an increased risk of morbidity and mortality. We aimed to evaluate …

… The first draft of the manuscript was written by Nilüfer Ülkü Şahin and Nihal Şahin and all
authors commented on previous versions of the manuscript. All authors read and approved the …

… and analysis were performed by [Nihal Sahin], [Sumeyra Ozdemir Cicek] and [Aysenur
Pac Kisaarslan]. The first draft of the manuscript was written by [Nihal Sahin] and all authors …

Objectives Familial Mediterranean fever (FMF) may present with various concomitant diseases.
This study aims to evaluate the clinical characteristics of patients with FMF with Juvenile …

Background and Aim Chronic diseases profoundly impact people’s quality of life (QoL).
Behçet’s Disease (BD) is a multisystemic chronic disease characterized by vasculitis of various …

Background Methotrexate (MTX) is the first‐choice disease‐modifying drug in juvenile
idiopathic arthritis (JIA) treatment. Methotrexate is metabolized in the liver and can cause liver …

Purpose Although less than one-third of anti-nuclear antibody (ANA) positive patients with
oJIA develop uveitis, ANA positivity is still the most well-known marker for assessing the risk of …